首页> 外文会议>2014 40th Annual Northeast Bioengineering Conference >MgO nanocomposites as new antibacterial materials for orthopedic tissue engineering applications
【24h】

MgO nanocomposites as new antibacterial materials for orthopedic tissue engineering applications

机译:MgO纳米复合材料作为骨科组织工程应用的新型抗菌材料

获取原文
获取原文并翻译 | 示例

摘要

Regeneration of orthopedic soft and hard tissues, such as ligaments, bone, and the tendon-to-bone insertion site (TBI), is problematic due to a lack of suitable biomaterials which possess appropriate mechanical properties capable of promoting cellular functions in these tissues with limited regenerative capacity. Additionally, surgically implanted biomaterials are susceptible to bacterial infection, which can lead to implant failure, as well as further complications such as wide-spread infection. To address these issues, the current study investigated magnesium oxide (MgO) nanoparticles as novel materials to improve orthopedic tissue regeneration and reduce bacterial infection. Poly (l-lactic acid) (PLLA) was mineralized with MgO nanoparticles and tested for its mechanical properties, bactericidal efficacy, and its ability to support the growth of fibroblasts and osteoblasts. These MgO nanocomposites were compared to PLLA mineralized with nanoparticles of hydroxyapatite (HA), which have been shown to promote bone tissue growth and have been widely used as materials for bone tissue engineering. Results indicated for the first time that MgO nanoparticles increased the adhesion and proliferation of osteoblasts and fibroblasts compared to plain PLLA and PLLA-HA nanocomposites. Furthermore, MgO nanocomposites showed excellent bactericidal efficacy, killing nearly all of the bacteria seeded onto them, whereas HA nanocomposites showed increased bacterial growth compared to plain PLLA. Mechanical tensile testing revealed that the addition of a secondary nano-phase to plain PLLA increased the material elastic modulus and reduced material elasticity. Moreover, the mechanical properties could be tuned to match those of bone or ligament tissue by varying nanoparticle size and concentration within the composite.
机译:骨科软,硬组织(如韧带,骨骼和肌腱-骨插入位点(TBI))的再生是有问题的,因为缺乏合适的生物材料,而这些材料具有能够促进这些组织中细胞功能的适当机械特性。再生能力有限。另外,外科植入的生物材料易受细菌感染,这可能导致植入失败,以及进一步的并发症,例如广泛感染。为了解决这些问题,当前的研究研究了氧化镁(MgO)纳米颗粒作为新型材料,以改善骨科组织的再生并减少细菌感染。聚(l-乳酸)(PLLA)用MgO纳米颗粒矿化,并测试其机械性能,杀菌功效以及其支持成纤维细胞和成骨细胞生长的能力。将这些MgO纳米复合材料与用羟基磷灰石(HA)纳米颗粒矿化的PLLA进行了比较,已证明它们可促进骨组织生长,并已广泛用作骨组织工程设计的材料。结果首次表明,与普通PLLA和PLLA-HA纳米复合材料相比,MgO纳米颗粒增加了成骨细胞和成纤维细胞的粘附和增殖。此外,MgO纳米复合材料显示出优异的杀菌功效,几乎杀死了所有播种在其上的细菌,而HA纳米复合材料与普通PLLA相比显示出增加的细菌生长。机械拉伸试验表明,在普通PLLA中添加次要纳米相会增加材料的弹性模量并降低材料的弹性。此外,可以通过改变复合物中纳米颗粒的大小和浓度来调整机械性能,使其与骨骼或韧带组织的机械性能相匹配。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号